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Olivier Jegaden*, Joel Lapeze, Fadi Farhart and Guy de GevigneyAbstract
We report a prospective comparison between transcatheter valve implantation (TAVI, n = 13) and surgical aortic
valve replacement (AVR, n = 10) in patients with severe aortic valve stenosis and previous coronary bypass surgery
(CABG). All patients had at least bilateral patent internal thoracic arteries bypass without indication of repeat
revascularization. After a similar post-procedure outcome, despite one early death in TAVI group, the 1-year survival
was 100% in surgical group and in transfemoral TAVI group, and 73% in transapical TAVI group. When previous
CABG is the lone surgical risk factor, indications for a TAVI procedure have to be cautious, specially if transfemoral
approach is not possible.Background
Aortic Valve surgery (AVR) after previous coronary artery
bypass (CABG) is always challenging and usually the indi-
cation of redo surgery is delayed because of the risk of
reoperation in old patients with patent arterial grafts. Few
years ago, we have described a surgical approach through
an inferior T hemisternotomy for aortic valve surgery in
patients with an in situ right internal mammary artery to
left anterior descending artery passing in front of the
ascending aorta, allowing a good surgical exposure and
providing good results with an adapted surgical strategy
[1]. Since the introduction of transcatheter aortic valve
implantation (TAVI), these patients are now referred to
this alternative therapeutic option as high risk patients
with an adverse thorax even if they only present technical
challenges to conventional AVR [2]. We report a prospect-
ive comparison between TAVI and AVR using our tech-
nique in patients with severe aortic valve stenosis (AS)
and previous CABG.
Methods
From May 2009 and December 2010, 23 patients with AS
and previous CABG were referred to our department for a
TAVI procedure. Mean age was 76±9 years (55–88), mean* Correspondence: olivier.jegaden@chu-lyon.fr
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reproduction in any medium, provided the orlogistic Euroscore was 25±15 (5.8–52) and mean delay
after CABG was 11±5 years (0.2–19). All patients had at
least both IMA grafting and all arterial grafts were patent
without indication for repeat revascularization. After the
screening, 13 patients underwent a TAVI procedure with
the implantation of a Sapien prothesis (Edwards life-
sciences, Irvine, CA) using a transapical approach (TA) in 9
or a transfemoral approach (TF) in 4, according to the
available vascular access, and 10 patients underwent a AVR
procedure with the implantation of a Magna bioprothesis
(Edwards life-sciences, Irvine, CA): 3 patients had refused
the “new” TAVI procedure and 7 patients had a too large
aortic annulus (>25 mm). In both group (TAVI and AVR),
patients were similar in age (76±11 vs 76±6,) and logistic
Euroscore (25±14 vs 25±16 respectively). In TAVI group,
the impairment of left ventricular ejection fraction was
higher (49±12 vs 57±9, ns) and the delay from CABG sur-
gery was shorter (9±6 vs 14±2, p< 0.01); in this group, 3
patients had a severe porcelain aorta and in 2 of them, AS
was known at the time of CABG surgery and the decision
of a further TAVI procedure was decided during the off-
pump CABG procedure in front of a “untouchable” aorta.
Written informed consent was obtained from the patient
for publication of this report and any accompanying
images.l Ltd This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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All TAVI procedures were done in catheterization la-
boratory under general anesthesia. In one patient with
porcelain aorta, an intra-ventricular migration of the
prothesis occurred during the TA procedure, leading to
the implantation of a second valve and then a surgical
removal of the first prothesis was successfully done
through a right mini-thoracotomy using a left atrial and
trans-mitral approach under beating heart. All other
TAVI and AVR procedures were successfully done. One
patient after TAVI procedure died on day 20th from gen-
eral weakness; he was 88-year old with logistic euroscore
52 and the indication was probably overtaken. The out-
comes of the patients are summarized in Table 1. After
AVR, extubation time was significantly longer and Tro-
pinin level (24th hours) was significantly higher. Transfu-
sion requirement was higher after AVR (ns). After TAVI,
pacemaker implantation was higher (ns) and 2 patients
had a paravalvular leak (grade 2). ICU stay and hospital
stay were similar in both group. There was no major ad-
verse event in both group as myocardial infraction,
stroke or vascular complication. The mean follow-up
was 1.2 year; one sudden death occurred 3 months after
a TAVI procedure. At 1 year, actuarial survival was 100%
in AVR group and 84 ± 21% in TAVI group (ns): 100% in
TF and 78 ± 28% in TA (ns).
Comments
Patients with AS after previous CABG are often distin-
guished by high risk factors for AVR: elderly, symptomatic
heart failure, long history of ischemic cardiomyopathy
with left ventricular impairment. Redo-surgery is technic-
ally challenging regarding the surgical approach, the myo-
cardial protection, the calcified aortic root, and specially
in case of patent arterial grafts. However, conventional
AVR as a redo procedure after CABG with patent grafts
can be performed with excellent results and a lower mor-
tality than estimated [3], even in case of both IMA grafts,Table 1 Outcome of patients after the procedure
AVR n=10 TAVI n = 13 p
Extubation time (hours) 6.5 ± 2.8 2.8 ± 1.9 <0,02
ICU Stay (Days) 1.2 ± 0.8 1 ± 0.8 ns
Tropinin (24th hours) 6.7 ± 7 3 ± 1.2 ns
Tranfusion requirement (%) 70% 38% ns
Pacemaker implantation (%) 20% 54% ns
Paravalvular leak (%) 0% 15% ns
30-day Mortality (%) 0% 7.5% ns
Hospitalstay (days) 11 ± 2,5 10 ± 3 ns
MACCE (Infarctus, stroke) 0 (%) 0 (%) ns
AVR, Aortic valve replacement; TAVI, transcatheter aortic valve implantation;
ICU, Intensive care unit; MACCE, Major adverse cardiac and cerebrovascular
event.thanks to the use of an adapted surgical strategy [1]. TAVI
procedure with its less invasive nature has been believed
to offer a safer treatment solution for high risk patients [2]
and we could expect to observe a benefit impact of TAVI
in the specific situation of patients with previous CABG.
According to our short series, the advantage of TAVI in
comparison with AVR is not obvious. Early mortality and
post-procedure outcome are quite similar: earlier extuba-
tion time, lower Troponin level and higher rate of pace-
maker implantation after TAVI have to be balanced
against higher rate of transfusion and no paravalvular leak
after AVR. The 1-year survival are the same after AVR
and transfemoral TAVI (100%) and lower after transapical
TAVI (78%) as if TA approach was more aggressive than
AVR for the ischemic and impaired underlying myocar-
dium. Concomitant coronary artery disease has been
demonstrated as a significant risk factor for mortality in
patients having TAVI [4]; in our series, the choice of op-
erative approach, either TA or TF, was found to be a risk
factor of mortality. In the randomized PARTNER trial [5],
TAVI and AVR were associated with similar rates of sur-
vival at 1-year; however, the results of the subgroup ana-
lyses suggested that TAVI was associated with higher
mortality than AVR among patients with a history of
CABG regardless the operative approach for TAVI; by ex-
perience, we could imagine that TA procedure had been
more frequent in this subgroup.
In an observational study, Drews et al. [6] reported that
previous heart surgery was not a risk factor in TA-TAVI:
early mortality and 1-year survival were similar in patients
with or without previous surgery, but the 1.5 year survival
observed was 73% in TAVI as first procedure and 52% in
TAVI as second procedure. Recently, Ducrocq et al. [7]
evaluated the impact of previous CABG on the outcome
of patients after TAVI procedure; conversely, previous
CABG was identified as an independent predictive factor
of better mid-trem survival, which is maybe related to re-
sidual bias in an observational study; however their study
confirmed that TA approach is more frequent in previous
CABG group (43% vs 26%) and that TA approach is a pre-
dictor of 2-year mortality.
Paradoxically, these data are not conflicting with the
results of the randomized PARTNER trial [5] and with
the short contribution of our series: 1) In comparison
with vascular approach, TA approach is a risk factor in
TAVI procedure, 2) The impact of previous CABG on
the outcome of patients after TAVI remains controver-
sial, but seems to be, 3) In patients with previous CABG
and eligible for TAVI or AVR, surgical replacement is
maybe better than TA-TAVI.
Limitations
Our series presents several limitations, mainly the lack
of randomization and the small number of patients.
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NER trial [5] that surgical replacement is maybe better
than TA-TAVI in patients with previous CABG.
Conclusion
Our series confirms that if TAVI can be considered as a
good alternative to AVR in patients with previous CABG
in order to avoid technical challenges of conventional sur-
gery, it is maybe not the best option when previous CABG
is the lone surgical risk factor for AVR and when transfe-
moral TAVI is not possible. Nowadays, in such patients
without a porcelain aorta, we are thinking about a trans-
aortic approach for TAVI procedure, through a right an-
terior mini thoracotomy (2nd ICS), as an alternative to the
transapical approach. Another alternative could be the
subclavian approach but it is not suitable to Sapien
prothesis.
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